You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hormone receptor positive/human epidermal growth factor receptor 2 negative (HR /HER2-)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Among Hormone Receptor-positive/Human Epidermal Growth Factor

Recruiting
  • Breast Cancer
    • Tokyo, Japan
      Pfizer Japan Inc.
    Nov 29, 2021

    HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

    Not yet recruiting
    • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
    • PERT-IJS plus trastuzumab, carboplatin and docetaxel
    • Perjeta plus trastuzumab, carboplatin and docetaxel
    • (no location specified)
    Sep 21, 2023

    Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Hospitalet de Llobregat, Barcelona, Spain
    • +6 more
    Jan 23, 2023

    Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer Trial in United States (NUV-422, Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • +7 more
    • Anaheim, California
    • +4 more
    Apr 6, 2022

    Breast Cancer, Chemo Effect Trial (Capecitabine)

    Not yet recruiting
    • Breast Cancer
    • Chemotherapy Effect
    • (no location specified)
    Mar 9, 2022

    Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage II Breast Cancer AJCC v8
    • +3 more
    • Biospecimen Collection
    • +7 more
    • Portland, Oregon
      SWOG
    Sep 27, 2023

    Breast Cancer Trial in Shanghai (HS-10352 combined with fulvestrant (Stage 1), HS-10352 combined with fulvestrant (Stage 2))

    Recruiting
    • Breast Cancer
    • HS-10352 combined with fulvestrant (Stage 1)
    • HS-10352 combined with fulvestrant (Stage 2)
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 15, 2022

    Metastatic Breast Cancer Trial in Zhengzhou (Famitinib, SHR6390, Fulvestrant)

    Recruiting
    • Metastatic Breast Cancer
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jan 25, 2022

    Among Patients Receiving Palbociclib Combinations for Hormone

    Recruiting
    • Breast Neoplasms
    • Palbociclib plus an aromatase inhibitor
    • Palbociclib plus fulvestrant
    • Doha, Qatar
      Hamad Medical Corporation
    Nov 18, 2021

    A NIS of Alpelisib in Combination With Fulvestrant in

    Not yet recruiting
    • Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
    • Alpelisib
    • Fulvestrant
    • (no location specified)
    Aug 9, 2022

    HR-positive,HER2-negative in Advanced Breast Cancer Trial in Beijing (TQB3616 capsules, TQB3616-matching , Fluvestrin injection)

    Recruiting
    • HR-positive,HER2-negative in Advanced Breast Cancer
    • TQB3616 capsules
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    May 11, 2022

    Breast Cancer Trial in Port Saint Lucie (RGT-419B, RGT-419B in combination with hormonal therapy)

    Recruiting
    • Breast Cancer
    • RGT-419B
    • RGT-419B in combination with hormonal therapy
    • Port Saint Lucie, Florida
      Hem-Onc Associates of the Treasure Coast
    Apr 18, 2022

    HR-positive, HER2-negative Breast Tumors Trial in China (TQB3616 capsule, Placebo, Fulvestrant injection)

    Not yet recruiting
    • HR-positive, HER2-negative Breast Neoplasms
    • TQB3616 capsule
    • +2 more
    • Bengbu, Anhui, China
    • +5 more
    May 6, 2022

    Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center
    Jan 17, 2022

    HR+/HER2- Advanced and/or Metastatic Breast Cancer Trial (HS-10342)

    Not yet recruiting
    • HR+/HER2- Advanced and/or Metastatic Breast Cancer
    • (no location specified)
    Sep 7, 2021

    Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed

    Active, not recruiting
    • Breast Neoplasms
    • Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
    • +7 more
    • Birmingham, Alabama
    • +26 more
    Dec 21, 2022

    Breast Cancer Trial in Spain (Palbociclib, Letrozole)

    Recruiting
    • Breast Cancer
    • Barcelona, Spain
    • +7 more
    Sep 3, 2021

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Orange City, Florida
    • +27 more
    Jul 19, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer Trial in Philadelphia (Palbociclib, Olaparib,

    Recruiting
    • Metastatic Breast Cancer
    • +4 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jul 20, 2021

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

    Not yet recruiting
    • Advanced Solid Tumor
    • +8 more
    • (no location specified)
    Nov 13, 2023